Drug Enforcement D-0127-2024

OOS for viscosity

Status

Terminated

Classification

Class III

Report Date

December 6, 2023

Termination Date

June 3, 2024

Product Information

Product description
Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30
Product quantity
—
Reason for recall
OOS for viscosity
Recall initiation reason
—
Initial firm notification
—
Distribution pattern
USA nationwide

Location & Firm

Recalling firm
Teva Pharmaceuticals USA, Inc
Address
400 Interpace Pkwy Bldg A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0127-2024
Event ID
93409
Recall initiation date
November 10, 2023
Center classification date
November 29, 2023
Code info
Lot #: 100029472, Exp. 2/29/2024
More code info
—